Bergapten
Thông số
484-20-8Số CAS
207-604-5Số EC
4-methoxyfuro[3,2-g]chromen-7-oneTên IUPAC
C12H8O4Công thức hóa học
216.19 g/molKhối lượng phân tử
Bergapten; 5-Methoxypsoralen; 484-20-8; bergaptene; Heraclin; Majudin; BERGAPTAN; 5-Mop; Psoraderm; O-Methylbergaptol; 5-Methoxy psoralen; 5-Methoxy-6,7-furanocoumarin; 5-Methoxyfuranocoumarin; 4-methoxyfuro[3,2-g]chromen-7-one; Geralen; 4-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-one; 7H-Furo[3,2-g][1]benzopyran-7-one, 4-methoxy-; 5 methoxypsoralen; DTXSID1025560; 4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one; NSC-95437; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, gamma-lactone; 4FVK84C92X; 7H-Furo(3,2-g)(1)benzopyran-7-one, 4-methoxy-; DTXCID305560; CHEBI:18293; 5-methoxy-2H-furo[3,2-g]chromen-2-one; 5 Methoxy Psoralen; 5-methoxy-2H-furo(3,2-g)chromen-2-one; 4-METHOXYFURO(3,2-G)CHROMEN-7-ONE; RefChem:29910; 207-604-5; 4-Methoxy-7H-furo[3,2-g]chromen-7-one; Pentaderm; 5-methoxypsoralene; 4-Methoxyfuro[3,2-g]benzopyran-7-one; MFCD00010272; NSC 95437; Bergaptene (DCF); 4-Methoxyfuro[3,2-g]benzopyrane-7-one; 5-Methoxypsoralen with ultraviolet A therapy; NSC95437; 4-Methoxy-furo[3,2-g]chromen-7-one; CHEMBL24171; 5-methoxyfurano[3,2-g]chromen-2-one; 4-Methoxy-7H-furo[3,2-g]benzopyran-7-one; 5-Methoxypsoralen; Bergapten; CAS-484-20-8; SMR000112435; CCRIS 4348; HSDB 3466; SR-05000002173; EINECS 207-604-5; BRN 0019560; UNII-4FVK84C92X; alpha-bergapten; 5-Methoxypsoralen (Bergapten); Heraclin;; Pentaderm (TN); 5-methoxy-psoralen; Bergapten (Standard); Spectrum_000794; BERGAPTEN [MI]; Spectrum2_000534; Spectrum3_000663; Spectrum4_001478; Spectrum5_000155; 5-Methoxypsoralen, 99%; bmse000758; 5-Methoxypsoralen (obsol.); 7H-Furo[3, 4-methoxy-; Oprea1_562364; SCHEMBL50066; BSPBio_002325; KBioGR_002055; KBioSS_001274; SPECTRUM300546; 5-19-06-00004 (Beilstein Handbook Reference); MLS002207272; MLS002454380; Bergapten, analytical standard; DivK1c_000529; SPBio_000547; MEGxp0_000990; orb1224973; orb1306366; orb3025861; SCHEMBL29529284; ACon0_000984; ACon1_001979; GTPL12431; HMS501K11; HY-N0370R; KBio1_000529; KBio2_001274; KBio2_003842; KBio2_006410; KBio3_001545; 5-METHOXYPSORALEN [IARC]; NINDS_000529; HMS1923G13; HMS2268M24; HMS3652F19; HMS5082N16; Pharmakon1600-00300546; 5-METHOXYPSORALEN [MART.]; 5-METHOXYPSORALEN [WHO-DD]; HY-N0370; TNP00299; Tox21_202357; Tox21_303255; BDBM50067880; CCG-39946; MSK000532; NSC755877; s4239; STK333038; AKOS000276715; DB12216; DS-2970; EBC-457062; FM05395; NSC-755877; SDCCGMLS-0066492.P001; IDI1_000529; 4-Methoxyfuro[3,2-?]benzopyrane-7-one; NCGC00017357-01; NCGC00017357-02; NCGC00017357-03; NCGC00017357-04; NCGC00017357-05; NCGC00017357-06; NCGC00017357-07; NCGC00017357-08; NCGC00091582-01; NCGC00091582-02; NCGC00091582-03; NCGC00091582-04; NCGC00178705-01; NCGC00178705-02; NCGC00256998-01; NCGC00259906-01; AC-20189; AC-34208; NCI60_042121; ST057259; SY051831; SBI-0051583.P002; DB-051552; NS00015832; SW220008-1; T2143; 4-Methoxy-7H-furo[3,2-g]chromen-7-one #; C01557; D07521; AB00052148_06; AB00052148_07; F328941; Q414779; Q-100536; SR-05000002173-2; SR-05000002173-3; SR-05000002173-5; BRD-K12968785-001-02-6; BRD-K12968785-001-03-4; BRD-K12968785-001-06-7; BRD-K12968785-001-11-7; BRD-K12968785-001-12-5; BRD-K12968785-001-13-3; 6-Hydroxy-4-methoxy-5-benzofuranacrylic acid, .gamma.-lactone; InChI=1/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1HTên gọi khác